Novo CEO pressed by Senate to cut charges of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen told lawmakers the company would contemplate new talks with insurers concerning the listing price ranges of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Never miss out on https://lorenzoukarh.tinyblogging.com/considerations-to-know-about-healthcare-news-74395617